← Eichor
Study identifier: NCT06832163 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Close Loop Smart Weaning for INO With PPHN

Condition: Persistent Pulmonary Hypertension of the Newborn · Inhaled Nitric Oxide  ·  Sponsor: Children's Hospital of Fudan University

PhaseNA
Planned participants30
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

In contemporary clinical practice concerning the administration of inhaled nitric oxide (iNO) within neonatal intensive care units (NICUs), a stepwise reduction approach is frequently employed in accordance with established neonatal guidelines. Nonetheless, the comparative advantages of a linear reduction strategy-characterized by a gradual decrease in inhalation concentration-over the traditional stepwise method in terms of efficacy and safety have yet to be conclusively established. Furthermore, existing iNO delivery devices necessitate that healthcare professionals manually adjust parameters at intervals dictated by the patient's condition. This reliance on subjective clinical judgment often results in variability and a lack of standardization in the duration of the weaning process. Additionally, the protracted and intricate nature of the weaning procedure considerably heightens the workload for healthcare staff. Importantly, the development of a scientifically grounded, standardized, and real-time feedback mechanism for weaning may enhance clinical outcomes for patients and mitigate the risks associated with inappropriate weaning practices or inconsistent manual interventions. Consequently, this study seeks to leverage the newly introduced "intelligent closed-loop weaning" feature of the latest generation of iNO devices to facilitate automated linear concentration reduction during the weaning process. This innovation aims to alleviate the burden on healthcare personnel wh…

This description comes directly from the study's public registry record.

Talk to the study team

Zhicheng Zhu  ·  +86 13601911685  ·  jonney116@sina.com

Weiling Kong  ·  +8613547827448  ·  kongwling@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Children's Hospital of Fudan UniversityShanghai, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06832163